Tiamate

   
Google
 
Web NewDrugInformation.com

Tiamate


Drug - Tiamate
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Diltiazem Malate
Multiple ingredients are in alphabetical order.

Strength - EQ 180MG HCL
The potency of the active ingredient(s), Diltiazem Malate. May repeat for multiple part products.

Applicant - MERCK
The firm name holding legal responsibility for Tiamate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020506
The FDA assigned number to Tiamate. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Tiamate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 4, 1996
The date Tiamate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tiamate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Tiamate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Merck And Co Inc
The full name of the firm holding legal responsibility for the new application of Tiamate.

Tiamate